back
Get SIGNAL/NOISE in your inbox daily
A new model known as BoltzGen designs protein binders for any biological target from scratch. Developed at MIT, BoltzGen has shown promise for hard-to-treat targets in cancer and neurodegenerative diseases.
Recent Stories
Jan 14, 2026
Corporate legal departments are cutting costs with AI
Corporate legal teams are becoming eager adopters of AI tools that cut tasks from days to minutes.
Jan 14, 2026Nvidia Gets U.S. Approval to Ship AI Chips to China. Now It Waits on Beijing.
Nvidia stock was reacting to news the Trump administration had finalized the requirements for the chip maker to sell its H200 chips in China.
Jan 14, 2026